Your participation in the trial may impact your current treatment schedule and routine, and it’s essential to understand how the trial will fit into your overall care plan. 

Developing treatments for conditions like glioblastoma is intricate. The journey covers: 

• Phase I: Initial testing on a small group to evaluate safety and side effects. 
• Phase II: Testing on a larger group to understand its safety and effectiveness further. 
• Phase III: Comparing the new treatment to existing treatments on an even larger group. 
• Phase IV: Monitoring approved treatments to ensure continued safety and effectiveness. 

Clinical trials are conducted in diverse settings beyond major cancer centers. They take place in local hospitals, research facilities, and community centers, making them accessible to a broader group of participants. 

Clinical trials often explore new treatments or combinations of treatments that are not yet available as standard care. They may offer innovative approaches that could potentially improve outcomes for patients.

Participation in clinical trials is entirely voluntary. Participants have the autonomy to withdraw at any time, ensuring they are comfortable and in control of their treatment journey. 

Clinical trials encompass a range of cancer stages, including early detection, treatment, and prevention studies. They offer innovative treatment options for various stages of cancer, not solely as a last resort for advanced cases.